Gibbs, E., Karim, M. E., Oger, J., Steering Committee of the BENEFIT study, Edan, G., Freedman, M. S., . . . Sandbrink, R. (2015). Antibody dissociation rates are predictive of neutralizing antibody (NAb) course: A comparison of interferon beta-1b-treated Multiple Sclerosis (MS) patients with transient versus sustained NAbs. Clinical immunology (Orlando, Fla.), 157(1), 91. https://doi.org/10.1016/j.clim.2014.12.005
Style de citation ChicagoGibbs, Ebrima, et al. "Antibody Dissociation Rates Are Predictive of Neutralizing Antibody (NAb) Course: A Comparison of Interferon Beta-1b-treated Multiple Sclerosis (MS) Patients with Transient Versus Sustained NAbs." Clinical Immunology (Orlando, Fla.) 157, no. 1 (2015): 91. https://dx.doi.org/10.1016/j.clim.2014.12.005.
Style de citation MLAGibbs, Ebrima, et al. "Antibody Dissociation Rates Are Predictive of Neutralizing Antibody (NAb) Course: A Comparison of Interferon Beta-1b-treated Multiple Sclerosis (MS) Patients with Transient Versus Sustained NAbs." Clinical Immunology (Orlando, Fla.), vol. 157, no. 1, 2015, p. 91.